Email: cspc@cspc.cn

Contact Us

CSPC Pharmaceutical Group Co., Ltd.

News

News

Home > Media > News > CRB-701 (SYS6002) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA

CRB-701 (SYS6002) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA

December 04, 2024

Next: VOLUNTARY ANNOUNCEMENT FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020) OBTAINS FURTHER CLINICAL TRIAL APPROVAL FOR NEW INDICATION

Phone:

+86 311 8703 7015

Email:

Legal terms Privacy protection

Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |